William A. Hawkins, former chairman and CEO of Medtronic, will replace outgoing Immucor CEO Joshua Levine, after he steps down from the role Oct. 17, according to a statement from the company’s board of directors.
Hawkins’ career includes more than 30 years in medical technology companies, as well as roles in Washington, D.C., that helped shape healthcare policies and matters involving the FDA. Upon becoming CEO, Hawkins will also serve as senior advisor to TPG Capital, Immucor’s parent company.
Outgoing CEO Levine cited distance from his family as the reason for stepping down from the role.
The Norcross, Ga.-based company develops and sells reagents and systems used to detect and identify cell and serum components of human blood prior to blood transfusions.